What’s on the Agenda?

What would you like to see on the Cord Blood Connect agenda?

Committees have been working since November on an agenda that they believe will meet your needs and interests. You have an opportunity to give them your thoughts below.

Here’s what they are planning:

There will be several plenary sessions designed for everyone. The rest of the two-and-a-half days will be concurrent sessions in two tracks. One track will be scientific, with clinicians and investigators providing updates on their work at the leading edges of laboratory research and clinical trials in cord blood therapeutics and regenerative medicine. The other track will be education and training for cord blood banking administrators, lab technicians, collectors and other support personnel.

Specifically, this is the lineup . . .

Scientific Sessions

  • Late-breaking updates on clinical outcomes of cord blood transplantation
  • Improving the outcomes of cord blood transplantation: immune reconstitution, graft selection, novel conditioning regimens, post-transplant management
  • Immunomodulatory cord blood-derived therapies
  • Manufacturing of MSCs from birthing tissues: early phase clinical trials
  • Novel therapies derived from cord blood and cord tissue under development for non-transplant indications
  • A look to the future: the role of universal, off-the-shelf therapies versus personalized medicine/autologous therapies

Education and Training Sessions

  • Quality assurance: What does it mean to you?
  • How your cord blood bank can maintain financial health and sustainability
  • Ways to optimize interaction with potential industry partners
  • What you can learn from international regulatory agencies and registries
  • Challenges created by the interface of GMP with the practice of medicine

Other sessions related to banking regulations will include:

  • Evolving laws and regulations governing cord blood banking and therapies
  • Model international criteria for cord blood banking laws and regulations

The 15 organizations collaborating on the congress will be presenting other programs and workshops during or adjacent to the congress. For example, a day-long, pre-conference program on quality assurance, accreditation and inspector training will be presented by the Foundation for the Accreditation of Cellular Therapy (FACT) and the World Marrow Donor Association (WMDA). Also throughout the day prior to the congress, the Perinatal Stem Cell Society (PSCS) will be presenting sessions on therapeutic uses of amnion, amniotic fluid, cord blood, cord tissue and placenta.

Is there something important that is missing? A topic area that you and others would appreciate? Click here to tell us, and your recommendation will be forwarded to the appropriate planning committee.